Dr Darcy Benson, AUD | |
9 Oak Tree Ln, Belmont, CA 94002-3717 | |
(415) 518-2318 | |
Not Available |
Full Name | Dr Darcy Benson |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 9 Oak Tree Ln, Belmont, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609803675 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | AU693 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Darcy Benson, AUD 9 Oak Tree Ln, Belmont, CA 94002-3717 Ph: (415) 518-2318 | Dr Darcy Benson, AUD 9 Oak Tree Ln, Belmont, CA 94002-3717 Ph: (415) 518-2318 |
News Archive
In recent decades, patients in Europe coming in for colectomies, or surgical procedures targeted at the colon, have not been routinely subjected to what is known as bowel preparation, where the bowel is emptied before the operation. In the United States, on the other hand, cleansing the bowel is relatively common.
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that having a greater exercise capacity is associated with a significantly decreased all-cause mortality risk of between 25-33% in people with type 2 diabetes (T2D).
China Yongxin Pharmaceuticals, Inc. ("China Yongxin Pharmaceuticals" or the "Company"), is a leading manufacturer, distributor and retailer of Chinese traditional medicines, pharmaceutical products, natural health products, health food, cosmetics, and medical equipment in Northeastern China. The Company today announced that it had opened three new stores in 2009.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed gastroenterologists estimate that (assuming no new data on adverse events emerge) they will treat fewer Crohn's disease patients with Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade by the end of 2010, while the percentage of biologics-treated patients receiving Abbott/Eisai's Humira will increase to 36 percent.
Since 2003, 16 states have enacted legislation requiring insurance companies to provide health insurance coverage to dependent young adults on their parents, health plans beyond age 18 or 19, according to a new report from the Commonwealth Fund.
› Verified 9 days ago